MAVORIC Kyowa Hakko Kirin

Company News

Kyowa Kirin reports positive results from MAVORIC study

Japan-based Kyowa Hakko Kirin has reported positive results from the Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL (MAVORIC) study after…